OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid

Sheridan, Cormac
October 2012
BioWorld Today;10/23/2012, Vol. 23 Issue 206, p2
The article reports on the 27.4 million euro-cash buyout offer accepted by OctoPlus NV from Dr. Reddy's Laboratories Ltd. The event has pushed OctoPlus share price up by 23 percent. Dr. Reddy's is now planning to proceed with a recommended public offer for all the outstanding shares of OctoPlus. Dr. Reddy's plan to maintain the OctoPlus identity and its facility in Leiden, the Netherlands.


Related Articles

  • Dr Reddy's Inks commercialisation Deal with Hatchtech.  // eHEALTH;9/16/2015, p1 

    The article reports on the commercialization contract signed by pharmaceutical company Dr. Reddy's Laboratories Ltd. with Australian pharmaceutical company Hatchtech Pty. Ltd., for the development of an innovative prescription head lice product Xeglyze lotion.

  • Pharma: Other News To Note.  // BioWorld Today;2/13/2013, Vol. 24 Issue 30, p9 

    The article offers news briefs related to pharmaceutical industry, such as the public offer of Dr. Reddy's Laboratories Ltd. for acquiring OctoPlus NV's outstanding and issued shares and the complete response letter (CRL) sent to Novo Nordisk A/S by the U.S. Food and Drug Administration (FDA).

  • DRL to acquire BMS Laboratories and Meridian Healthcare UK.  // Pharmaceutical Technology Asia;Aug2002, p7 

    Focuses on an agreement signed by Dr Reddy's Laboratories (DRL) to acquire BMS Laboratories Limited and Meridian Healthcare. Impact of the agreement on the expansion efforts of DRL.

  • Beyond betapharm. Sharma, E. Kumar // Business Today;3/21/2010, Vol. 19 Issue 6, p90 

    The article focuses on the emergence of problems after the acquisition of German generics company betapharm Arzneimittel GmbH by Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. It notes that the German government introduced healthcare sector reforms which converted branded generics...

  • Dr Reddy's ready to drive down costs. Cameron, Amanda // New Zealand Doctor;9/24/2008, p35 

    The article features Affordable Healthcare, a New Zealand company acquired by Indian generics manufacturer Dr. Reddy in April 2008. Affordable Healthcare was created in 2003 as a distributor of Dr. Reddy's products and was later set-up for acquisition by Dr. Reddy. Affordable Healthcare won the...

  • Indian Firm Buys Roche API Business Unit in Mexico. Scott, Alex // Chemical Week;11/23/2005, Vol. 167 Issue 40, p25 

    The article reports on the agreement of Dr. Reddy's Laboratories (DRL), a producer of drugs and active pharmaceutical ingredients (API), to acquire Roche's API manufacturing business at Cuernavaca, Mexico. The acquisition deal includes all existing business supply contracts, including ongoing...

  • Dr. Reddy's acquires Roche's API business.  // Chemical Market Reporter;11/14/2005, Vol. 268 Issue 17, p5 

    Reports that Dr. Reddy's Laboratories Ltd. has signed a definitive agreement to acquire Roche Pharmaceuticals' active ingredients business in Cuernavac, Mexico. Terms of the agreement; Significance of the venture to Dr. Reddy's portfolio; Statement of Dr. Reddy CEO G. V. Prasad on the potential...

  • Dr. Reddy's -- The Turnaround.  // Pharmaceutical Executive;Sep2011, Vol. 31 Issue 9, pS5 

    The article presents an interview with Satish Reddy, chief operating officer (COO) of Dr. Reddy's Laboratories Ltd. When asked about the results of 2010 in which Dr. Reddy's was the best performer in the stock exchange, Reddy said the cost reduction strategy was responsible for better results....

  • A Prescription for Change. Kumar Sharma, E. // Business Today;12/2/2007, Vol. 16 Issue 24, p194 

    The article presents information on recent developments associated with Indian business enterprise DR Reddy's Laboratories. Recently DR Reddy's has acquired two companies including one in Mexico and another in Germany. G.V. Prasad, Vice-Chairman, the chief executive officer (CEO) of Dr Reddy's...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics